治疗非霍奇金淋巴瘤(NHL)是一件不易的事情,但临床医生和研究者正努力研究各种治疗的方法。在过去的十年里,人们对这一疾病过程的理解进入到分子水平——有潜力的精确的靶向治疗成为治疗淋巴瘤的一个新的选择,为更长期的缓解、更少的副反应以及治愈更多的患者铺平了道路。研究以一种令人眩晕的速度开展着,在美国至少有200个临床试验召募了NHL患者。 Treating non-Hodgkin’s lymphoma (NHL) is not easy, but clinicians and researchers are trying to find ways to treat them. In the past decade, people’s understanding of the process of the disease has entered the molecular level - the potential of precise targeted therapies as a new option for the treatment of lymphoma for longer-term relief, fewer side effects As well as to cure more patients paved the way. The study was conducted at a dizzying rate of at least 200 clinical trials in the United States recruiting NHL patients.